Vimarsana
Biggest News Aggregation in the World

Page 4 - Insight Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Insight Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Insight Reports Today - Breaking & Trending Today

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a - Vimarsana News

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a

Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher...

CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency - Vimarsana News

CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 31, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...

Centogene N : Announces Change in Supervisory Board - Form 6-K -Today at 04:34 pm - Vimarsana News

Centogene N : Announces Change in Supervisory Board - Form 6-K -Today at 04:34 pm

CENTOGENE Announces Change in Supervisory Board CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, August 18, 2023 - CENTOGENE N.V. , the essential life science partner for...

CENTOGENE to Participate in Upcoming Conferences in August - Vimarsana News

CENTOGENE to Participate in Upcoming Conferences in August

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...

CENTOGENE Regains Compliance With Nasdaq Listing Requirements - Vimarsana News

CENTOGENE Regains Compliance With Nasdaq Listing Requirements

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 14, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...